Abstract
Health-related quality of life in people with intellectual disabilities can be affected by challenging behaviors and side effects of antipsychotics. The aim of this study was to evaluate the effect of discontinuation antipsychotic drugs on health-related quality of life, including data from 2 discontinuation trials: an open-label trial of various antipsychotic drugs and a double-blind trial of risperidone. In both studies, antipsychotics were discontinued in 14 weeks, with steps of 12.5% of the baseline dosage every 2 weeks. Health-related quality of life was measured at baseline and at 16 weeks, and 40 weeks after baseline, by means of the RAND-36 (domains on physical well-being, role limitations caused by physical or emotional problems, vitality, pain, mental well-being, social functioning, general health, and changes in health). Participants who had completely discontinued antipsychotics according to the scheduled discontinuation and were still free of use at 40 weeks were compared with those who had incompletely discontinued. Physical well-being showed an increase in the group that had achieved complete discontinuation. Social functioning showed a decrease in the group that incompletely discontinued, which recovered at foll...Continue Reading
References
May 2, 2000·The British Journal of Psychiatry : the Journal of Mental Science·Z AhmedJ Thomas
Aug 9, 2001·Annals of Medicine·R D Hays, L S Morales
Nov 16, 2001·American Journal of Mental Retardation : AJMR·J R ZarconeS R Schroeder
Mar 29, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·David B AllisonDiana D McDonnell
Jun 10, 2004·The Onderstepoort Journal of Veterinary Research·M Barson
Jan 26, 2005·Psychopharmacology·Carllo GagianoIlse Van Hove
Dec 5, 2006·Schizophrenia Research·Guy FaulknerHyacinth Irving
Jan 8, 2008·Lancet·Peter TyrerMike Crawford
Apr 30, 2010·Journal of Intellectual Disability Research : JIDR·Gerda de KuijperH Evenhuis
Jun 29, 2010·Research in Developmental Disabilities·Johnny L Matson, Sara Mahan
Oct 11, 2012·Journal of Intellectual Disability Research : JIDR·G de KuijperP J Hoekstra
Jun 19, 2013·Journal of Clinical Psychopharmacology·Gerda de KuijperPieter J Hoekstra
Jun 25, 2013·Research in Developmental Disabilities·Gerda de KuijperPieter J Hoekstra
Oct 19, 2013·Journal of Clinical Psychopharmacology·Gerda M de KuijperPieter J Hoekstra
Feb 15, 2014·World Journal of Clinical Cases·Crispin Schneider, David F Hewin
Feb 15, 2014·World Journal of Clinical Cases·Federico GobbiZeno Bisoffi
Feb 15, 2014·World Journal of Clinical Cases·Elena LionettiMario La Rosa
Aug 4, 2015·Research in Developmental Disabilities·Andrea D KochMatthias Schützwohl
Dec 10, 2015·Research in Developmental Disabilities·Arlette ScheifesEibert R Heerdink
Jun 1, 2017·Journal of Intellectual Disability Research : JIDR·G M de Kuijper, P J Hoekstra
Jun 24, 2017·Journal of Intellectual Disability Research : JIDR·M O'DwyerM C Henman
Sep 1, 2017·Health Technology Assessment : HTA·Rachel McNamaraMichael Kerr
Feb 27, 2018·Research in Developmental Disabilities·Lotte RamermanGerda de Kuijper